CARsgen carsgen.com


Public list: Pharma Startups (4733) Healthcare Horizons (27) Cancer Therapeutics (1136)

CARsgen (科济生物) is an immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has relationships with Shanghai Cancer Institute and Shanghai Renji Hospital, plans to initiate clinical trials for KJgpc3-001, a glypican-3 (GPC3)-directed CAR-T cell therapy for liver cancer, and is advancing CAR-T therapies for lung and brain cancers in parallel. Funded by leading venture capital firm...Show all

CARsgen (科济生物) is an immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has relationships with Shanghai Cancer Institute and Sh...Show all

Company (Alive / Active)

Phone: 86-21-54489928

Fax:

Suite 401, Building 3, 466 Yindu Road, Xuhui

Shanghai, 200231
Shanghai, China

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CARsgen $90M Mar 2, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CARsgen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Board Members

There is no Competitors data available for this company. Please select another tab.